Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Applied Biosystems Complete Merger

NEW YORK (GenomeWeb News) – As expected, Invitrogen and Applied Biosystems have completed their $6.7 billion merger today, Invitrogen announced.
The combined company will be called Life Technologies and will begin trading on the Nasdaq exchange under the symbol “LIFE” on Monday, Nov. 24.
As reported yesterday by GenomeWeb Daily News, ABI’s shareholders overwhelmingly opted to receive all cash for their shares. Around 84 percent of the outstanding shares elected to receive all cash, while 2 percent elected to receive Invitrogen stock and 7 percent elected to receive a mixed consideration of cash and stock. Another 7 percent did not make a valid election and therefore will receive mixed consideration.
Invitrogen said today that those stockholders who elected the cash option will receive slightly more cash and slightly fewer shares than they would have received if they had chosen the mixed stock and cash consideration. The firm intends to provide a final election tally and prorated disbursement figures by Nov. 28. Proceeds will be disbursed no later than the first week of December.
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.